Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Short-term Investments (2021 - 2026)

Core Scientific has reported Short-term Investments over the past 6 years, most recently at $60.2 million for Q1 2026.

  • Quarterly results put Short-term Investments at $60.2 million for Q1 2026, up 7594.0% from a year ago — trailing twelve months through Mar 2026 was $60.2 million (up 7594.0% YoY), and the annual figure for FY2024 was $783000.0, down 95.94%.
  • Short-term Investments reached $60.2 million in Q1 2026 per CORZ's latest filing, up from $783000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $279.2 million in Q1 2022 and bottomed at $783000.0 in Q3 2024.
  • Median Short-term Investments over the past 5 years was $17.7 million (2023), compared with a mean of $35.5 million.
  • The largest annual shift saw Short-term Investments crashed 96.41% in 2024 before it skyrocketed 7594.0% in 2026.
  • Over 5 years, Short-term Investments stood at $36.4 million in 2022, then tumbled by 46.91% to $19.3 million in 2023, then tumbled by 95.94% to $783000.0 in 2024, then changed by 0.0% to $783000.0 in 2025, then surged by 7594.0% to $60.2 million in 2026.
  • Business Quant data shows Short-term Investments for CORZ at $60.2 million in Q1 2026, $783000.0 in Q1 2025, and $783000.0 in Q4 2024.